Gamma Interferon Mediates Propionibacterium Acnes-induced Hypersensitivity to Lipopolysaccharide in Mice
Overview
Affiliations
Pretreatment of lipopolysaccharide (LPS)-responder C57BL/10ScSn mice with killed Propionibacterium acnes enhanced tumor necrosis factor alpha (TNF-alpha) production and lethality in response to a subsequent challenge with LPS. Sensitization to LPS increased with time of pretreatment and reached its maximum after 7 days. Sensitization was paralleled by gamma interferon (IFN-gamma) production that was detectable from day 3 onward. In contrast, a similar P. acnes pretreatment of LPS-nonresponder C57BL/10ScCr mice had no apparent effect on their high resistance to LPS. Challenge with LPS at any time during the 7-day period after P. acnes treatment led to no detectable TNF-alpha formation and caused no lethal effects. The absence of sensitization in C57BL/10ScCr mice was paralleled by an absence of IFN-gamma production. Administration of monoclonal IFN-gamma antibodies in C57BL/10ScSn mice up to day 3 of P. acnes treatment completely inhibited the overproduction of TNF-alpha by LPS. Anti-IFN-gamma administered later than day 3 had only a partial, although significant, inhibitory effect. Injection of appropriate amounts of anti-IFN-gamma also abolished the development of hypersensitivity to the lethal action of LPS. The effect of exogenously administered IFN-gamma on LPS sensitivity (e.g., TNF-alpha production, lethal effects) was studied in LPS-responder and nonresponder mice. Administration of murine recombinant IFN-gamma increased the sensitivity of C57BL/10ScSn mice to LPS and established LPS responsiveness in LPS-nonresponder C57BL/10ScCr and C3H/HeJ mice. The data provide evidence that IFN-gamma mediates the sensitization towards LPS induced by P. acnes.
Sharma M, Ferguson P Curr Opin Rheumatol. 2013; 25(5):658-64.
PMID: 23917160 PMC: 4912130. DOI: 10.1097/BOR.0b013e328363eb08.
Tchaptchet S, Gumenscheimer M, Kalis C, Freudenberg N, Holscher C, Kirschning C PLoS One. 2012; 7(6):e39155.
PMID: 22745710 PMC: 3382180. DOI: 10.1371/journal.pone.0039155.
Darmani H, Harwood J, Parton J, Jackson S Mediators Inflamm. 1995; 4(1):25-30.
PMID: 18475612 PMC: 2365606. DOI: 10.1155/S0962935195000056.
Carnitine and congeners as regulators of tumour necrosis factor.
De Simone C, Martelli E, Foresta P Mediators Inflamm. 1993; 2(7):S3.
PMID: 18475567 PMC: 2365450. DOI: 10.1155/S0962935193000663.
Bacterial endotoxins: biological properties and mechanisms of action.
Galanos C, Freudenberg M Mediators Inflamm. 1993; 2(7):S11-6.
PMID: 18475562 PMC: 2365449. DOI: 10.1155/S0962935193000687.